WuXi AppTec Co., Ltd. (HKG: 2359)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
56.05
+0.65 (1.17%)
Nov 7, 2024, 11:06 AM HKT

WuXi AppTec Company Description

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.

The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others.

It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.

The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; and drug discovery services to pharmaceutical and biotech customers.

In addition, the company offers consulting services for combinatorial chemistry and pharmaceuticals; and develops computer software and databases.

Further, it is involved in pharmaceutical research and development; pharmacology, toxicology, and safety evaluation research services; and new drug clinical development and on-site management services.

WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.

WuXi AppTec Co., Ltd.
WuXi AppTec logo
Country China
Founded 2000
Industry Diagnostics & Research
Sector Healthcare
Employees 41,116
CEO Ge Li

Contact Details

Address:
288 Fute Zhong Road
Shanghai, 200131
China
Phone 86 21 5046 1111
Website wuxiapptec.com

Stock Details

Ticker Symbol 2359
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100003F19
SIC Code 8731

Key Executives

Name Position
Dr. Edward Hu M.B.A. Vice Chairman, Global Chief Investment Officer, Chief Executive Officer of WuXi ATU and Head of DDSU
Dr. Qing Yang Ph.D. Co-Chief Executive Officer and Executive Director
Dr. Minzhang Chen Ph.D. Co-Chief Executive Officer and Executive Director
Dr. Ge Li Ph.D. Co-Founder, Chairman, President and Chief Executive Officer
Ming Shi Senior Vice President and Chief Financial Officer
Zhaohui Zhang Chief Operating Officer of China, Executive Vice President and Executive Director
Yuanzhou Zhang Joint Company Secretary
Ruijia Tang IR Director
Dr. Howard Wu J.D. Senior Vice President, General Counsel and Global Head of Human Resources
Dr. Jingchao Dong Ph.D. Senior Vice President and Head of RCS